Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Tallantyre

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Neurology|April 3, 2016
Continuous evolution of magnetic resonance imaging in multiple sclerosisE C Tallantyre, N P Robertson
Journal of Neurology|December 16, 2014
Acute stroke managementE C Tallantyre, N P Robertson
Journal of Neurology|April 24, 2015
Traumatic brain injury: pathophysiology, clinical outcome and treatmentO H Williams, E C Tallantyre, N P Robertson
Journal of Neurology|March 8, 2018
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammationE C Tallantyre, D H Whittam, S Jolles, et al.
Neurology|May 29, 2008
Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRIE C Tallantyre, M J Brookes, J E Dixon, et al.
Journal of Neurology|April 9, 2018
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammationE C Tallantyre, D H Whittam, S Jolles, et al.
Neurology|February 9, 2011
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesionsE C Tallantyre, J E Dixon, I Donaldson, et al.
Brain : a Journal of Neurology|May 8, 2009
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive diseaseE C Tallantyre, L Bø, O Al-Rawashdeh, et al.
Brain and Behavior|May 7, 2025
Multiple Sclerosis and Seizures: Clinical, Diagnostic and Therapeutic CorrelationsC Wood, S Owen, S Ebden, et al.
European Journal of Neurology|January 17, 2018
Multiple sclerosis: long-term outcomes in ethnic minorities. Analysis of a UK population-based registryM O Alsaeed, K E Harding, O H Williams, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Neurology|April 3, 2016
Continuous evolution of magnetic resonance imaging in multiple sclerosisE C Tallantyre, N P Robertson
Journal of Neurology|December 16, 2014
Acute stroke managementE C Tallantyre, N P Robertson
Journal of Neurology|April 24, 2015
Traumatic brain injury: pathophysiology, clinical outcome and treatmentO H Williams, E C Tallantyre, N P Robertson
Journal of Neurology|March 8, 2018
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammationE C Tallantyre, D H Whittam, S Jolles, et al.
Neurology|May 29, 2008
Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRIE C Tallantyre, M J Brookes, J E Dixon, et al.
Journal of Neurology|April 9, 2018
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammationE C Tallantyre, D H Whittam, S Jolles, et al.
Neurology|February 9, 2011
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesionsE C Tallantyre, J E Dixon, I Donaldson, et al.
Brain : a Journal of Neurology|May 8, 2009
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive diseaseE C Tallantyre, L Bø, O Al-Rawashdeh, et al.
Brain and Behavior|May 7, 2025
Multiple Sclerosis and Seizures: Clinical, Diagnostic and Therapeutic CorrelationsC Wood, S Owen, S Ebden, et al.
European Journal of Neurology|January 17, 2018
Multiple sclerosis: long-term outcomes in ethnic minorities. Analysis of a UK population-based registryM O Alsaeed, K E Harding, O H Williams, et al.
Pageof 2